Polyomavirus nephropathy: a current perspective and clinical considerations.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesEvaluation of fluoroquinolones for the prevention of BK viremia after renal transplantationBK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infectionTacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft RejectionOutcome in Pancreas Grafts After BK Virus Viremia in Simultaneous Pancreas-Kidney Transplants: A Single-Center Case Report.Polyomavirus BK neutralizing activity in human immunoglobulin preparations.BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremiaRisk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences.Human polyoma viruses and disease with emphasis on clinical BK and JC.Outcomes in pediatric solid-organ transplantation.Renal relevant radiology: imaging in kidney transplantation.BK virus infection: an update on diagnosis and treatment.Acute interstitial nephritis - a reappraisal and update.Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury.CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.The association between killer-cell immunoglobulin-like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.JC viraemia in kidney transplant recipients: to act or not to act?Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.Polyomavirus Nephropathy in Native Kidneys of an Immunocompetent Individual.Adenovirus interstitial nephritis and rejection in an allograftEvaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy.BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report.A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients.Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center.
P2860
Q21285083-AD332A02-950C-46B1-9BD3-977253CC018BQ24627138-973A6EEC-52C6-43AC-A259-3E00470598FBQ28070240-CF6332F7-4E1A-4B47-B830-DB456B366CE7Q33694700-143996DF-CED9-4A7A-A4D6-9CFF44A05EA6Q33719816-46899A7A-EC0D-4013-BCF0-6B2CAC6A8C66Q34786755-1AF8B8A2-FCB2-42C3-92A6-ED904E08AC91Q35099077-1E0EB0AE-506B-44A8-B680-DDA44C350518Q35664634-437DD70A-C412-45CB-A386-CF0D15C685FEQ35930371-D68C103E-8020-4F47-A32E-FB879CC3DAEEQ36272108-14FD28AB-EE10-4EC5-961B-7C32F4866643Q37155134-D82F153A-F83A-483C-AA1F-D6CC4E430FBEQ37671117-7CBDF20C-4EB7-4085-85D3-FF7F9E0509F6Q37839213-2F50BD57-5B53-4B93-8F31-23CA126D8C55Q38160726-B5DC7C73-380C-41D2-B0E2-616DE4A922E0Q38191554-C6D36ED3-80E5-4072-9BF5-5C3AA6F3C11FQ38235631-8660840B-7A23-4C96-8041-8AF0F2862417Q38723077-201B1929-2B0E-47EF-9DF8-04784E3C0079Q38747503-59FD86B8-BA4D-4555-889F-D00428E558DFQ39180715-06F9F6D2-12BD-4FB7-981E-39185416D6FCQ40483890-11628EA2-C470-4EB8-B5BA-3A4D6C06F4ECQ40685015-1647C284-7C00-4F5D-B34A-94A360A7A56BQ41548443-F8510477-FA4A-46DC-8202-536840F4EB01Q41930175-5F4FBA3B-AF7F-409E-BC20-3ED46C0E4F47Q42160724-8596A722-A573-4175-98A3-32499A30345BQ43436078-367E52F4-B78D-4E15-A890-A6E976224360Q44763558-1CB02D8D-D93D-4F55-931A-C0ED88F02921Q45160805-5BFB62C3-9B5F-4EA8-963C-5B831DE8A1ACQ45366195-1BF9E0D8-5DB5-437D-9878-A70559221F79Q54353206-2DCF3BF5-53E9-47D5-9155-AC4E8C076D2D
P2860
Polyomavirus nephropathy: a current perspective and clinical considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polyomavirus nephropathy: a current perspective and clinical considerations.
@en
Polyomavirus nephropathy: a current perspective and clinical considerations.
@nl
type
label
Polyomavirus nephropathy: a current perspective and clinical considerations.
@en
Polyomavirus nephropathy: a current perspective and clinical considerations.
@nl
prefLabel
Polyomavirus nephropathy: a current perspective and clinical considerations.
@en
Polyomavirus nephropathy: a current perspective and clinical considerations.
@nl
P1476
Polyomavirus nephropathy: a current perspective and clinical considerations.
@en
P2093
Alexander C Wiseman
P304
P356
10.1053/J.AJKD.2009.01.271
P577
2009-04-25T00:00:00Z